4//SEC Filing
Anderman Jonathan 4
Accession 0001171843-25-000825
CIK 0001738021other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:09 PM ET
Size
5.5 KB
Accession
0001171843-25-000825
Insider Transaction Report
Form 4
Anderman Jonathan
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2025-02-11+280,000→ 280,000 totalExercise: $3.65Exp: 2035-02-11→ Common Stock (280,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0002032625
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:09 PM ET
- Size
- 5.5 KB